PLRZ — POLYRIZON LTD. ORDINARY SHARES (Healthcare >> Biotechnology)
PLRZ FAQ
What is PLRZ's ROE?
POLYRIZON LTD. ORDINARY SHARES reports a Return on Equity (ROE) of -15.89%.
What is PLRZ's dividend yield?
POLYRIZON LTD. ORDINARY SHARES offers a dividend yield of 0.00%.
What is PLRZ's Deepscope Quality Score?
Deepscope rates PLRZ's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PLRZ?
Deepscope's AI Timing Score for PLRZ is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PLRZ belong to?
POLYRIZON LTD. ORDINARY SHARES is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 11.06
Price
-0.39
(-3.41%)
Day Change
|
|
|---|
PLRZ, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 11.06 |
| PBV / Sector |
0.85 / 4.79
GREAT
|
| Earning Per Share | -2.07 |
| PE / Sector |
N/A / 17.89
|
| PEG or PE/Growth / Sector |
N/A / 0.56
|
| Average 1M Daily Value |
0.49 M
GREAT
|
| Average 1W Daily Value |
0.33 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-11 09:55:19 |
| Symbol | PLRZ |
| Name | POLYRIZON LTD. ORDINARY SHARES |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 2.08 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 17.79 / 8,963.32 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 5 HaPnina Street, Ra'anana, Israel, 4321545
Phone: 972 9 374 0120
Website: https://www.polyrizon-biotech.com
Sector: Healthcare >> Biotechnology
Description: Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google